Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SMAD3 |
| Upstream (Parents) |
|---|
| (<<) ADAMTS7 → SMAD3 |
| (<<) ANKRD37 → SMAD3 |
| (<<) BBS1 → SMAD3 |
| (<<) BCAM → SMAD3 |
| (<<) BCL2 → SMAD3 |
| (<<) BCL2A1 → SMAD3 |
| (<<) CASP5 → SMAD3 |
| (<<) CHSY1 → SMAD3 |
| (<<) EP300 → SMAD3 |
| (<<) FAM48A → SMAD3 |
| (<<) IGFBP4 → SMAD3 |
| (<<) IL1F7 → SMAD3 |
| (<<) KCTD5 → SMAD3 |
| (<<) LOC441245 → SMAD3 |
| (<<) MAN2A2 → SMAD3 |
| (<<) MAP3K14 → SMAD3 |
| (<<) NAV2 → SMAD3 |
| (<<) NFIL3 → SMAD3 |
| (<<) RAB22A → SMAD3 |
| (<<) SMURF1 → SMAD3 |
| (<<) TCEB1 → SMAD3 |
| Downstream (Children) |
|---|
| SMAD3 → CACNA1I (>>) |
| SMAD3 → MAPK9 (>>) |
| SMAD3 → SALL2 (>>) |
